{{Rsnum
|rsid=8193036
|Gene=IL17A
|Chromosome=6
|position=52185695
|Orientation=plus
|GMAF=0.3779
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL17A
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.6 | 41.1 | 55.4
| HCB | 46.0 | 46.0 | 8.0
| JPT | 38.1 | 47.8 | 14.2
| YRI | 5.4 | 36.1 | 58.5
| ASW | 3.5 | 47.4 | 49.1
| CHB | 46.0 | 46.0 | 8.0
| CHD | 56.0 | 36.7 | 7.3
| GIH | 13.9 | 55.4 | 30.7
| LWK | 17.3 | 46.4 | 36.4
| MEX | 12.1 | 34.5 | 53.4
| MKK | 17.9 | 51.3 | 30.8
| TSI | 2.9 | 33.3 | 63.7
| HapMapRevision=28
}}
{{PMID|19210369}} pediatric [[asthma]] in a Taiwanese population.

{{PMID Auto
|PMID=22483685
|Title=Interactions between IL17A, IL23R, and STAT4 polymorphisms confer susceptibility to intestinal Behcet's disease in Korean population
}}

{{PMID|20173782}} Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation.

{{PMID Auto
|PMID=23131423
|Title=Interleukin-17A genetic variants can confer resistance to brucellosis in Iranian population
}}

{{PMID Auto
|PMID=23485736
|Title=Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population
}}

{{PMID Auto
|PMID=23280722
|Title=IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
}}

{{PMID Auto
|PMID=23460603
|Title=Polymorphisms of Interleukin-1 Beta and Interleukin-17Alpha Genes Are Associated With Restless Legs Syndrome.
}}

{{PMID Auto
|PMID=24919468
|Title=Influence of the IL17A locus in giant cell arteritis susceptibility
}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}